The Evaluation of adding tecar therapy effect on routine physiotherapy treatments compared to placebo tecar and routine physiotherapy treatments on pain, disability and electrical activity of erector spine muscles in patients with non-specific chronic low back pai

Not Applicable

Recruiting

• Conditions: non-specific chronic low back pain.; Other disorders of the musculoskeletal system and connective tissue; M95-M99

• Registration Number: IRCT20221101056358N1
• Lead Sponsor: Semnan University of Medical Sciences

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 7 February 2023

Recruitment & Eligibility

• Status: Recruiting
• Sex: All
• Target Recruitment: 32

Inclusion Criteria

Patients with symptoms of chronic back pain who are between 20 and 60 years old
Diagnosis of chronic back pain for at least 12 weeks
Visual pain index 4-7
Patients with back pain who have no documentation of discopathy or disc herniation

Exclusion Criteria

Contraindication of tecar therapy: neoplasm, regional infection, patients with cardiac pacemaker and pregnancy.
Active vertebral fracture
previous spine surgery
Rheumatoid diseases such as rheumatoid arthritis
infectious diseases
Systemic diseases that affect pain perception, such as diabetes and...
Local injection such as (local anesthesia, corticosteroid...)
Taking medicines and doing physiotherapy in the last 4 weeks

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Pain. Timepoint: Before the intervention and two weeks after the intervention and 1 month after the end of the last session of the intervention. Method of measurement: visual analogue scale- -.;Functional disability. Timepoint: Before the intervention and two weeks after the intervention and 1 month after the end of the last session of the intervention. Method of measurement: Oswestry disability scale.;Electrical activity of erector spine muscles. Timepoint: Before the intervention and two weeks after the intervention and 1 month after the end of the last session of the intervention. Method of measurement: Electromyographic device.